The CCK-B antagonist CI-988 increases dopamine levels in microdialysate from the rat nucleus accumbens via a tetrodotoxin- and calcium-independent mechanism

Rebecca L. Corwin, Andreas Jörn, Melva Hardy, Jacqueline Crawley

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

CI-988, a water-soluble, selective cholecystokinin-B antagonist, was perfused through a microdialysis probe into the anterior nucleus accumbens, posterior nucleus accumbens, or caudate nucleus of anesthetized rats. High concentrations of CI-988 produced three- to fivefold increases in dopamine overflow, at all three sites, that were temporally correlated with the CI- 988 perfusion and returned to baseline levels upon cessation of CI-988 perfusion. However, the cholecystokinin-A antagonist CAM-1481, and the relatively inactive enantiomer of CI-988, CAM-1241, also increased dopamine overflow in the nucleus accumbens. Furthermore, the ability of CI-988 to increase dopamine overflow persisted in the absence of calcium in the perfusate and was not sensitive to tetrodotoxin treatment. The mechanism by which locally administered CI-988 increases dopamine overflow appears not to be anatomically specific, not selective for one cholecystokinin receptor subtype, and may be nonvesicular.

Original languageEnglish (US)
Pages (from-to)208-217
Number of pages10
JournalJournal of Neurochemistry
Volume65
Issue number1
StatePublished - Jul 1995
Externally publishedYes

Fingerprint

Tetrodotoxin
Nucleus Accumbens
Rats
Dopamine
Calcium
Cholecystokinin
Perfusion
Cholecystokinin Receptors
Enantiomers
Caudate Nucleus
Microdialysis
Computer aided manufacturing
PD 134308
Water

Keywords

  • Cholecystokinin
  • In vivo microdialysis
  • Mesolimbic
  • Neuropeptide
  • Receptor
  • Release

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

The CCK-B antagonist CI-988 increases dopamine levels in microdialysate from the rat nucleus accumbens via a tetrodotoxin- and calcium-independent mechanism. / Corwin, Rebecca L.; Jörn, Andreas; Hardy, Melva; Crawley, Jacqueline.

In: Journal of Neurochemistry, Vol. 65, No. 1, 07.1995, p. 208-217.

Research output: Contribution to journalArticle

@article{39554d17bd8d41c296b1a09d61fb2a94,
title = "The CCK-B antagonist CI-988 increases dopamine levels in microdialysate from the rat nucleus accumbens via a tetrodotoxin- and calcium-independent mechanism",
abstract = "CI-988, a water-soluble, selective cholecystokinin-B antagonist, was perfused through a microdialysis probe into the anterior nucleus accumbens, posterior nucleus accumbens, or caudate nucleus of anesthetized rats. High concentrations of CI-988 produced three- to fivefold increases in dopamine overflow, at all three sites, that were temporally correlated with the CI- 988 perfusion and returned to baseline levels upon cessation of CI-988 perfusion. However, the cholecystokinin-A antagonist CAM-1481, and the relatively inactive enantiomer of CI-988, CAM-1241, also increased dopamine overflow in the nucleus accumbens. Furthermore, the ability of CI-988 to increase dopamine overflow persisted in the absence of calcium in the perfusate and was not sensitive to tetrodotoxin treatment. The mechanism by which locally administered CI-988 increases dopamine overflow appears not to be anatomically specific, not selective for one cholecystokinin receptor subtype, and may be nonvesicular.",
keywords = "Cholecystokinin, In vivo microdialysis, Mesolimbic, Neuropeptide, Receptor, Release",
author = "Corwin, {Rebecca L.} and Andreas J{\"o}rn and Melva Hardy and Jacqueline Crawley",
year = "1995",
month = "7",
language = "English (US)",
volume = "65",
pages = "208--217",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - The CCK-B antagonist CI-988 increases dopamine levels in microdialysate from the rat nucleus accumbens via a tetrodotoxin- and calcium-independent mechanism

AU - Corwin, Rebecca L.

AU - Jörn, Andreas

AU - Hardy, Melva

AU - Crawley, Jacqueline

PY - 1995/7

Y1 - 1995/7

N2 - CI-988, a water-soluble, selective cholecystokinin-B antagonist, was perfused through a microdialysis probe into the anterior nucleus accumbens, posterior nucleus accumbens, or caudate nucleus of anesthetized rats. High concentrations of CI-988 produced three- to fivefold increases in dopamine overflow, at all three sites, that were temporally correlated with the CI- 988 perfusion and returned to baseline levels upon cessation of CI-988 perfusion. However, the cholecystokinin-A antagonist CAM-1481, and the relatively inactive enantiomer of CI-988, CAM-1241, also increased dopamine overflow in the nucleus accumbens. Furthermore, the ability of CI-988 to increase dopamine overflow persisted in the absence of calcium in the perfusate and was not sensitive to tetrodotoxin treatment. The mechanism by which locally administered CI-988 increases dopamine overflow appears not to be anatomically specific, not selective for one cholecystokinin receptor subtype, and may be nonvesicular.

AB - CI-988, a water-soluble, selective cholecystokinin-B antagonist, was perfused through a microdialysis probe into the anterior nucleus accumbens, posterior nucleus accumbens, or caudate nucleus of anesthetized rats. High concentrations of CI-988 produced three- to fivefold increases in dopamine overflow, at all three sites, that were temporally correlated with the CI- 988 perfusion and returned to baseline levels upon cessation of CI-988 perfusion. However, the cholecystokinin-A antagonist CAM-1481, and the relatively inactive enantiomer of CI-988, CAM-1241, also increased dopamine overflow in the nucleus accumbens. Furthermore, the ability of CI-988 to increase dopamine overflow persisted in the absence of calcium in the perfusate and was not sensitive to tetrodotoxin treatment. The mechanism by which locally administered CI-988 increases dopamine overflow appears not to be anatomically specific, not selective for one cholecystokinin receptor subtype, and may be nonvesicular.

KW - Cholecystokinin

KW - In vivo microdialysis

KW - Mesolimbic

KW - Neuropeptide

KW - Receptor

KW - Release

UR - http://www.scopus.com/inward/record.url?scp=0028998551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028998551&partnerID=8YFLogxK

M3 - Article

C2 - 7790862

AN - SCOPUS:0028998551

VL - 65

SP - 208

EP - 217

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 1

ER -